We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,831 hedge funds and large institutions have $168B invested in Johnson & Johnson in 2013 Q3 according to their latest regulatory filings, with 85 funds opening new positions, 679 increasing their positions, 868 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 85 | Existing positions closed: 30

2% more funds holding

Funds holding: 1,7931,831 (+38)

4% more capital invested

Capital invested by funds: $162B → $168B (+$6.31B)

6% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $1.91B

1.07% less ownership

Funds ownership: 66.96%65.88% (-1.1%)

7% less funds holding in top 10

Funds holding in top 10: 649606 (-43)

22% less repeat investments, than reductions

Existing positions increased: 679 | Existing positions reduced: 868

Holders
1,831
Holders Change
+38
Holders Change %
+2.12%
% of All Funds
59.35%
Holding in Top 10
606
Holding in Top 10 Change
-43
Holding in Top 10 Change %
-6.63%
% of All Funds
19.64%
New
85
Increased
679
Reduced
868
Closed
30
Calls
$1.79B
Puts
$1.91B
Net Calls
-$121M
Net Calls Change
-$124M
Name Holding Trade Value Shares
Change
Change in
Stake
TAM
951
Tealwood Asset Management
Minnesota
$4.92M -$61.7K -688 -1%
FDS
952
First Dallas Securities
Texas
$4.89M -$79.5K -886 -2%
ST
953
Smithfield Trust
Pennsylvania
$4.89M -$6.91K -77 -0.1%
SGAM
954
Steinberg Global Asset Management
Florida
$4.89M +$151K +1,686 +3%
SC
955
Saybrook Capital
North Carolina
$4.88M -$172K -1,918 -3%
CC
956
ClearArc Capital
Ohio
$4.85M -$2.14M -23,870 -30%
PWP
957
Private Wealth Partners
California
$4.84M -$169K -1,880 -3%
Aristotle Capital Management
958
Aristotle Capital Management
California
$4.84M -$162K -1,801 -3%
GWI
959
Grace & White Inc
New York
$4.83M
DLCIG
960
D.L. Carlson Investment Group
New Hampshire
$4.83M +$192K +2,140 +4%
IPRC
961
Indices-Pac Research Corporation
New Jersey
$4.82M +$2.74M +30,556 +122%
NAM
962
NTV Asset Management
West Virginia
$4.82M -$391K -4,363 -7%
HCC
963
Hirtle Callaghan & Co
Pennsylvania
$4.81M +$4.6M +51,238 +1,196%
CPC
964
Cookson Peirce & Co
Pennsylvania
$4.8M +$129K +1,440 +3%
SGK
965
Steigerwald Gordon & Koch
Virginia
$4.79M +$495K +5,516 +11%
AWM
966
Altavista Wealth Management
North Carolina
$4.79M -$11.4K -127 -0.2%
AAIM
967
American Assets Investment Management
California
$4.77M +$89.7K +1,000 +2%
CAM
968
Cubic Asset Management
Massachusetts
$4.76M -$44K -490 -0.9%
JFGIW
969
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$4.73M -$140K -1,557 -3%
PWAP
970
Private Wealth Advisors (Pennsylvania)
Pennsylvania
$4.71M -$98.7K -1,100 -2%
WIC
971
Woodmont Investment Counsel
Tennessee
$4.7M -$122K -1,355 -2%
PHS
972
Pekin Hardy Strauss
Illinois
$4.7M -$993K -11,064 -17%
AIC
973
Argus Investors Counsel
New York
$4.69M -$367K -4,090 -7%
CCM
974
Condor Capital Management
New Jersey
$4.68M -$28K -312 -0.6%
CBB
975
Citizens Business Bank
California
$4.63M +$144K +1,610 +3%

JNJ Hedge Fund Activity: Q3 2013 in Review

1,831 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2013, worth a combined $168B — up 3.9% from $162B a quarter earlier.

Buyers outnumbered sellers: 85 funds opened new JNJ positions and 30 closed out — a net gain of 55 holders — while 679 added to existing stakes and 868 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $495M. The largest seller was Goldman Sachs, cutting an estimated $1.15B.

  • 1,831 institutional investors held Johnson & Johnson (JNJ) as of Q3 2013, up from 1,793 in Q2 2013.
  • Funds reported $168B of Johnson & Johnson stock for Q3 2013, up 3.9% quarter-over-quarter.
  • 85 funds opened new Johnson & Johnson positions in Q3 2013 and 30 closed out, a net change of +55 holders.
  • The largest Johnson & Johnson buyer in Q3 2013 was JP Morgan Chase, an estimated $495M added.
  • The largest Johnson & Johnson seller in Q3 2013 was Goldman Sachs, an estimated $1.15B sold.

Based on aggregated 13F filings for Q3 2013.